Hologic price target lowered to $75 from $85 at Wells Fargo

Wells Fargo lowered the firm’s price target on Hologic to $75 from $85 and keeps an Equal Weight rating on the shares following quarterly results. The firm believes the company’s core growth and capital allocation opportunities are fairly appreciated at current levels.